These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20806742)

  • 21. Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy.
    Vernon SA; Bhagey J; Boraik M; El-Defrawy H
    Diabet Med; 2009 Jan; 26(1):97-9. PubMed ID: 19125769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical treatment of diabetic retinopathy].
    Korda V
    Vnitr Lek; 2007 May; 53(5):509-11. PubMed ID: 17642434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
    Gerke E; Alvira G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):5-8. PubMed ID: 2421045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
    Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
    Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOPTOSIS AND ANGIOFIBROSIS IN DIABETIC TRACTIONAL MEMBRANES AFTER VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION: Results of a Prospective Trial. Report No. 2.
    Jiao C; Eliott D; Spee C; He S; Wang K; Mullins RF; Hinton DR; Sohn EH
    Retina; 2019 Feb; 39(2):265-273. PubMed ID: 29190236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review.
    Fong DS; Girach A; Boney A
    Retina; 2007 Sep; 27(7):816-24. PubMed ID: 17891003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine, single session, indirect laser for proliferative diabetic retinopathy.
    Tinley CG; Gray RH
    Eye (Lond); 2009 Sep; 23(9):1819-23. PubMed ID: 19136919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Nohutcu AF; Horozoglu F; Celik E
    Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proliferative diabetic retinopathy: laser photocoagulation treatment].
    Snyers B
    Bull Soc Belge Ophtalmol; 1995; 256():87-94. PubMed ID: 8581236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Persistent diabetic macular edema--surgical versus laser therapy].
    Brănişteanu D; Robu M; Irimia A
    Oftalmologia; 2007; 51(1):74-9. PubMed ID: 17605276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.
    Kolacny D; Parys-Vanginderdeuren R; Van Lommel A; Stalmans P
    Bull Soc Belge Ophtalmol; 2005; (296):15-23. PubMed ID: 16050416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation.
    Khosla PK; Rao V; Tewari HK; Kumar A
    Ophthalmic Surg; 1994 Aug; 25(8):516-20. PubMed ID: 7970533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
    Ishida S; Shinoda K; Kawashima S; Oguchi Y; Okada Y; Ikeda E
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1649-56. PubMed ID: 10845581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of posterior hyaloid membrane to pathogenesis and transciliary surgery of proliferative diabetic retinopathy].
    Sdobnikova SV; Stoliarenko GE
    Vestn Oftalmol; 1999; 115(1):11-3. PubMed ID: 10232994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Personal experience in the treatment of proliferative diabetic retinopathy using an argon laser].
    Chrapek O; Rehák J
    Cesk Slov Oftalmol; 2001 Jul; 57(4):244-9. PubMed ID: 11512438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.